Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats

Journal of Neurophysiology

Volumn 93, Issue 4, 2005, Pages 1989-2001

  Homayoun, Houman ^a   Jackson, Mark E ^a   Moghaddam, Bita ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; EGLUMETAD; GLUTAMATE RECEPTOR AGONIST; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; MALE; NERVE CELL; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PSYCHOSIS; RAT; RECEPTOR UPREGULATION; SPIKE WAVE; STEREOTYPY; SYSTEMIC CIRCULATION; WAKEFULNESS;

ACTION POTENTIALS; ANIMALS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; WAKEFULNESS;

EID: 15544385061     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00875.2004     Document Type: Article

References (78)

1. Adams B and Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18: 5545-5554, 1998.
2. Adler CM, Goldberg TE, Malhotra AK, Pickar D, and Breier A. Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry 43: 811-816, 1998.
3. Aultman JM and Moghaddam B. Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task. Psychopharmacologia 153: 353-364, 2001.
4. Baddeley R, Abbott L, Booth M, Sengpiel F, Freeman T, Wakeman E, and Rolls E. Responses of neurons in primary and inferior temporal visual cortices to natural scenes. Proc R Soc Lond B Biol Sci 264: 1775-1783. 1997.
5. Battaglia G, Monn JA, and Schoepp DD. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats. Neurosci Lett 229: 161-164, 1997.
6. Boraud T, Bezard E, Bioulac B, and Gross CE. From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control. Prog Neurobiol 66: 265-283, 2002.
7. Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, and Pickar D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry 154: 805-811, 1997.
8. Buffalo E, Gillam M, Allen R, and Paule M. Acute behavioral effects of MK-801 in rhesus monkeys: assessment using an operant test battery. Pharmacol Biochem Behav 48: 935-940, 1994.
9. Carlsson A, Svensson A, and Carlsson ML. Future Strategies in the Discovery of New Antipsychotic Agents: Focus on Dopamine-Glutamate Interactions. Basel: Karger, 1993.
10. Carlsson M and Carlsson A. Interactions between glutamatergic and mono-aminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci 13: 272-276, 1990.
11. Cartmell J, Monn JA, and Schoepp DD. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther 291: 161-170, 1999.
12. Cartmell J and Schoepp DD. Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75: 889-907, 2000.
13. Compte A, Constantinidis C, Tegner J, Raghavachari S, Chafee M, Goldman-Rakic P, and Wang X. Temporally irregular mnemonic persistent activity in prefrontal neurons of monkeys during a delayed response task. J Neurophysiol 90: 3441-3454, 2003.
14. Cooper DC. The significance of action potential bursting in the brain reward circuit. Neurochem Int 41: 333-340, 2002.
15. Cooper DC and White FJ. L-Type calcium channels modulate glutamate-driven bursting activity in the nucleus accumbens in vivo. Brain Res 880: 212-218, 2000.
16. Coyle JT, Tsai G, and Goff DC. Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr Drug Target CNS Neurol Disord 1: 183-189, 2002.
17. Crider A. Perseveration in schizophrenia. Schizophr Bull 23: 63-74, 1997.
18. Dingledine R, Hynes M, and King G. Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice. J Physiol 380: 175-189, 1986.
19. Duncan GE, Miyamoto S, Leipzig JN, and Lieberman JA. Comparison of the effects of clozapine, risperidone and olanzapine on ketamine-induced alterations in regional brain metabolism. J Pharmacol Exp Ther 293: 8-14, 2000.
20. East SJ, Hill MP, and Brotchie JM. Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes. Eur J Pharmacol 111: 117-121, 1995.
21. Feenstra M, Botterblom M, and van Uum J. Behavioral arousal and increased dopamine efflux after blockade of NMDA-receptors in the prefrontal cortex are dependent on activation of glutamatergic neurotransmission. Neuropharmacology 42: 752-763, 2002.
22. Ferris P, Seward E, and Dawson G. Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze. J Psychopharmacol 15: 76-82, 2001.
23. Gemmell C, Anderson M, and O'Mara SM. Deep layer prefrontal cortex unit discharge in a cue-controlled open-field environment in the freely-moving rat. Cereb Cortex 133: 1-10, 2002.
24. Geyer M and Moghaddam B. Animal models relevant to schizophrenia disorder. In: Psychopharmacology: The Fifth Generation of Progress, edited by Davis KL, Charney C, Coyle JT, and Nemeroff C. Philadelphia, PA: Lippincott/Williams & Wilkins, 2002.
25. Helton DR, Tizzano JP, Monn JA, Schoepp DD, and Kallman MJ. Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J Pharmacol Exp Ther 284: 651-660, 1998.
26. Higgins G, Ballard T, Kew JN, Richards JG, Kemp J, Adam G, Weltering T, Nakanishi S, and Mutel V. Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent. Neuropharmacology 46: 907-917, 2004.
27. Holt G, Softky W, Koch C, and Douglas R. Comparison of discharge variability in vitro and in vivo in cat visual cortex neurons. J Neurophysiol 75: 1806-1814, 1996.
28. Homayoun H and Moghaddam B. Ensemble single unit recording in awake rats reveals different patterns of plasticity in orbitofrontal and prefrontal cortices in response to an amphetamine sensitization paradigm. Soc Neurosci Abstr 25: 438.433, 2004.
29. Jackson M, Homayoun H, and Moghaddam B. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci USA 101: 6391-6396, 2004.
30. Jackson ME and Moghaddam B. Plasticity of prefrontal cortex response to stress: ensemble single-unit recording in awake rats. Soc Neurosci Abstr 25: 781.714, 2004.
31. Javitt D, Silipo G, Cienfuegos A, Shelley A, Bark N, Park M, Lindenmayer J, Suckow R, and Zukin S. Adjunctive high-dose glycine in the treatment of schizophrenia. Int J Neuropsychopharmacol 4: 385-391, 2001.
32. Javitt DC, Steinschneider M, Schroeder CE, and Arezzo JC. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci USA 93: 11962-11967, 1996.
33. Jentsch JD, Tran A, Taylor JR, and Roth RH. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence. Psychopharmacology 138: 89-95, 1998.
34. Jung M, Qin Y, McNaughton B, and Barnes C. Firing characteristics of deep layer neurons in prefrontal cortex in rats performing spatial working memory tasks. Cereb Cortex 8: 437-450, 1998.
35. Kaneoke Y and Vitek JL. Burst and oscillation as disparate neuronal properties. J Neurosci Methods 68: 211-223, 1996.
36. Kilbride J, Huang L, Rowan M, and Anwyl R. Presynaptic inhibitory action of the group II metabotropic glutamate receptor agonists, LY354740 and DCG-IV. Eur J Pharmacol 356: 149-157, 1998.
37. Knable MB and Weinberger DR. Dopamine, the prefrontal cortex and schizophrenia. J Psychopharmacol 11: 123-131, 1997.
38. Koek W, Woods J, and Winger G. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245: 969-974, 1988.
39. Krystal JH, Abi-Saab W, Perry E, D'Souza DC, Liu N, Gueorguieva R, McDougall L, Hunsberger T, Belger A, Levine L, and Breier A. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology (Berl) In press.
40. Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, and Hoffman R, NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl) 169: 215-233, 2003.
41. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers M Jr, and Charney DS. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214, 1994.
42. Lahti AC, Koffel B, LaPorte D, and Tamminga CA. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13: 9-19, 1995.
43. Lee D, Port N, Kruse W, and Georgopoulos A. Variability and correlated noise in the discharge of neurons in motor and parietal areas of the primate cortex. Neurosci 18: 1161-1170, 1998.
44. Legendy CR and Salcman M. Bursts and recurrences of bursts in the spike trains of spontaneously active striate cortex neurons. J Neurophysiol 53: 926-939, 1985.
45. Lewicki MS. A review of methods for spike sorting: the detection and classification of neural action potentials. Network Comput Neural Syst 9: R53-R78, 1998.
46. Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, and Varney MA. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 117: 697-706, 2003.
47. Malenka R and Nicoll R. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci 16: 521-527, 1993.
48. Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, and Breier A. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14: 301-307, 1996.
49. Marek G and Aghajanian G. The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis. Biol Psychiatry 44: 1118-1127, 1998.
50. Marek GJ, Wright RA, Schoepp DD, Monn JA, and Aghajanian GK. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther 292: 76-87, 2000.
51. Marino MJ and Conn PJ. Direct and indirect modulation of the N-methyl-D-aspartate receptor. Curr Drug Target CNS Neural Disord 1: 1-16, 2002.
52. McCormick DA, Connors BW, Lighthall JW, and Prince DA. Comparative electrophysiology of pyramidal and sparsely spiny stellate neurons of the neocortex. J Neurophysiol 54: 782-806, 1985.
53. Miller EK and Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 24: 167-202, 2001.
54. Moghaddam B. Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol Psychiatry 51: 775-787, 2002.
55. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 40: 881-884, 2003.
56. Moghaddam B and Adams B. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281: 1349-1352. 1998.
57. Moghaddam B, Adams B, Verma A, and Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921-2927, 1997.
58. Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, Hershey T, Craft S, and Olney JW. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20: 106-118, 1999.
59. Nilsson M, Carlsson A, and Carlsson M. Glycine and D-serine decrease MK-801-induced hyperactivity in mice. J Neural Transm 104: 1195-1205, 1997.
60. Olney J and Farber N. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52: 998-1007, 1995.
61. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press, 1986.
62. Poucet B. Searching for spatial unit firing in the prelimbic area of the rat medial prefrontal cortex. Behav Brain Res 84: 151-159, 1997.
63. Schmidt WJ. Behavioural effects of NMDA-receptor antagonists. J Neural Transm Suppl 43: 63-69, 1994.
64. Schoepp D, Jane D, and Monn J. Pharmacological agents acting as subtypes of metabotropic glutamate receptors. Neuropharmacology 38: 1431-1476, 1999.
65. Schoepp DD, Wright RA, Levine LR, Gaydos B, and Potter WZ. LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress. Stress 6: 189-197, 2003.
66. Schultz W and Dickinson A. Neuronal coding of prediction errors. Annu Rev Neurosci 23: 473-500, 2000.
67. Shi WX and Zhang XX. Dendritic glutamate-induced bursting in the prefrontal cortex: further characterization and effects of phencyclidine. J Pharmacol Exp Ther 305: 680-687, 2003.
68. Softky W and Koch C. The highly irregular firing of cortical cells is inconsistent with temporal integration of random EPSPs. J Neurosci 13: 334-350, 1993.
69. Spooren W, Ballard T, Gasparini F, Amalric M, Mutel V, and Schreiber R. Insight into the function of group I and group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders. Behav Pharmacol 14: 257-277, 2003.
70. Spooren W, Schoeffter P, Gasparini F, Kuhn R, and Gentsch C. Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). Eur J Pharmacol 435: 161-170, 2002.
71. Stefani MR, Groth K, and Moghaddam B. Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability. Behav Neurosci 117: 728-737, 2003.
72. Stoop R, Conquet F, Zuber B, Voronin L, and Pralong E. Activation of metabotropic glutamate 5 and NMDA receptors underlies the induction of persistent bursting and associated long-lasting changes in CA3 recurrent connections. J Neurosci 23: 5634-5644, 2003.
73. Swanson C, Perry K, and Schoepp D. The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex. J Neurochem 88: 194-202, 2004.
74. Takahata R and Moghaddam B. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychopharmacology 28: 1117-1124, 2003.
75. Tracy J, de Leon J, Qureshi G, McCann E, McGrory A, and Josiassen R. Repetitive behaviors in schizophrenia: a single disturbance or discrete symptoms? Schizophr Res 20: 221-229, 1996.
76. Tyszkiewicz J, Gu Z, Wang X, Cai X, and Yan Z. Group II metabotropic glutamate receptors enhance NMDA receptor currents via a protein kinase C-dependent mechanism in pyramidal neurones of rat prefrontal cortex. J Physiol 554: 765-777, 2004.
77. Verma A and Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 16: 373-279, 1996.
78. Vogels R, Spileers W, and Orban G. The response variability of striate cortical neurons in the behaving monkey. Exp Brain Res 77: 432-436, 1989.